Morgan Stanley downgraded by Keefe Bruyette with a new price target
$MS
Investment Bankers/Brokers/Service
Finance
Keefe Bruyette downgraded Morgan Stanley from Outperform to Mkt Perform and set a new price target of $91.00 from $102.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/15/2024 | $142.00 | Underweight → Equal Weight | Wells Fargo |
| 10/4/2024 | $118.00 | Hold → Buy | HSBC Securities |
| 9/11/2024 | Buy → Neutral | Goldman | |
| 8/2/2024 | $99.00 → $95.00 | Equal Weight → Underweight | Wells Fargo |
| 7/17/2024 | Outperform → Perform | Oppenheimer | |
| 1/17/2024 | $94.00 → $87.00 | Overweight → Neutral | JP Morgan |
| 1/17/2024 | $102.00 → $91.00 | Outperform → Mkt Perform | Keefe Bruyette |
| 1/9/2024 | $96.00 | Buy → Hold | HSBC Securities |
Morgan Stanley reports on the rising need for flexible structures in family offices Offices adapting to address need to uphold values, safeguard legacies, educate heirs, and maximize tech amid complex markets Morgan Stanley Wealth Management today released a comprehensive report identifying essential focus areas and recommended steps for family offices to target growth more effectively. With the number of family offices projected to expand 75% by 2030,1 trends indicate growing urgency and demand for adaptable structures that help families express values, protect legacies, educate the next generation and leverage technology to navigate cybersecurity challenges and change amid comple
Investment funds managed by Morgan Stanley Capital Partners ("MSCP"), the middle-market focused private equity team at Morgan Stanley Investment Management, have acquired FoodScience, a vertically integrated provider of pet and human nutritional supplements, from Wind Point Partners. Sharon Rossi will continue as FoodScience's Chief Executive Officer. Headquartered in Williston, Vermont, FoodScience drives a science-first approach to formulate, manufacture, market, and distribute nutritional supplements for pets and humans. FoodScience offers a broad portfolio of nutritional supplements through VetriScience®, DaVinci®, and Pet Naturals® brands, as well as private label and custom formulat
Morgan Stanley today declared a regular dividend on the outstanding shares of each of the following preferred stock issues: Floating Rate Non-Cumulative Preferred Stock, Series A - $358.35 per share (equivalent to $0.358347 per Depositary Share) 10 Percent Non-Cumulative Non-Voting Perpetual Preferred Stock, Series C - $25.00 per share Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series E - $455.21 per share (equivalent to $0.455208 per Depositary Share) Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series F - $439.24 per share (equivalent to $0.439236 per Depositary Share) Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series I - $407.29 per sh
Wells Fargo upgraded Morgan Stanley from Underweight to Equal Weight and set a new price target of $142.00
HSBC Securities upgraded Morgan Stanley from Hold to Buy and set a new price target of $118.00
Goldman downgraded Morgan Stanley from Buy to Neutral
FWP - MORGAN STANLEY (0000895421) (Subject)
FWP - MORGAN STANLEY (0000895421) (Subject)
FWP - MORGAN STANLEY (0000895421) (Subject)
Strategic investment is expected to accelerate Sokin's product growth plans and further global expansionAdditional investors include Gary Marino, former CCO at PayPal who will join the Board, Mark Britto, former CPO at PayPal, and Aurum Partners, the investment fund affiliated with the owners of the San Francisco 49ers and other strategic LPsExisting investors include Rio Ferdinand, former England and Manchester United defenderInvestment funds managed by Morgan Stanley Expansion Capital have acquired a stake in UK headquartered payments business Sokin, marking an exciting new chapter for the fast-expanding fintech firm. The acquisition will provide significant capital and accelerate its prod
Morgan Stanley (NYSE:MS) has outperformed the market over the past 10 years by 1.16% on an annualized basis producing an average annual return of 12.08%. Currently, Morgan Stanley has a market capitalization of $165.28 billion. Buying $1000 In MS: If an investor had bought $1000 of MS stock 10 years ago, it would be worth $3,087.09 today based on a price of $102.09 for MS at the time of writing. Morgan Stanley's Performance Over Last 10 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated content e
About 14% of the S&P 500 companies have reported their June quarter earnings and the blended earnings growth rate for the companies constituting the broader index remains healthy. The coming week will see the official start of the tech reporting season, which could potentially decide the fate of the market, which has seen a steep pullback in the recent week. The Week That Was: The tech earnings season had a modest start last week with the earnings report from chip-equipment maker ASML Holding N.V. (NASDAQ:ASML). The stock slumped about 16%, dragged by its weak third-quarter outlook and geopolitical concerns surrounding the China chip ban. Netflix, Inc.’s (NASDAQ:NFLX) guidance disappointe
4 - MORGAN STANLEY (0000895421) (Issuer)
4 - MORGAN STANLEY (0000895421) (Issuer)
4 - MORGAN STANLEY (0000895421) (Issuer)
Strategic investment is expected to accelerate Sokin's product growth plans and further global expansion Additional investors include Gary Marino, former CCO at PayPal who will join the Board, Mark Britto, former CPO at PayPal, and Aurum Partners, the investment fund affiliated with the owners of the San Francisco 49ers and other strategic LPs Existing investors include Rio Ferdinand, former England and Manchester United defender Investment funds managed by Morgan Stanley Expansion Capital have acquired a stake in UK headquartered payments business Sokin, marking an exciting new chapter for the fast-expanding fintech firm. The acquisition will provide significant capital and accel
VANCOUVER, BC, June 4, 2024 /CNW/ - RESAAS Services Inc. ("RESAAS") (TSXV:RSS) (OTCQB:RSASF), a leading provider of technology solutions for the real estate industry, today announced the appointment of James Huang to the role of Managing Director of Commercial Real Estate at RESAAS. Mr. Huang previously served as President of eXp Commercial, where, since 2020, he started and grew their Commercial division. Prior to eXp Commercial, Mr. Huang was President of Sperry Commercial Global Affiliates, where he led the company's expansion across more than 20 states and into multiple co
New funding brings Morgan Stanley's total commitment to $50 million since the launch of its Alliance for Children's Mental Health in 2020 The American Academy of Pediatrics and Sesame Workshop join Alliance to help expand programming to early childhood care and workforce development Morgan Stanley today announced a $20 million commitment over the next five years to its Alliance for Children's Mental Health ("Alliance"), bringing the initiative's total funding to $50 million since its launch in 2020. The Alliance will strengthen its work delivering programming and research, advancing transformative solutions through the Innovation Awards, and driving more impact for kids of all ages.
Investment funds managed by Morgan Stanley Capital Partners ("MSCP"), the middle-market focused private equity team at Morgan Stanley Investment Management, have acquired FoodScience, a vertically integrated provider of pet and human nutritional supplements, from Wind Point Partners. Sharon Rossi will continue as FoodScience's Chief Executive Officer. Headquartered in Williston, Vermont, FoodScience drives a science-first approach to formulate, manufacture, market, and distribute nutritional supplements for pets and humans. FoodScience offers a broad portfolio of nutritional supplements through VetriScience®, DaVinci®, and Pet Naturals® brands, as well as private label and custom formulat
Morgan Stanley today declared a regular dividend on the outstanding shares of each of the following preferred stock issues: Floating Rate Non-Cumulative Preferred Stock, Series A - $358.35 per share (equivalent to $0.358347 per Depositary Share) 10 Percent Non-Cumulative Non-Voting Perpetual Preferred Stock, Series C - $25.00 per share Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series E - $455.21 per share (equivalent to $0.455208 per Depositary Share) Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series F - $439.24 per share (equivalent to $0.439236 per Depositary Share) Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series I - $407.29 per sh
Morgan Stanley (NYSE:MS) today announced its third quarter 2024 financial results. The financial results are available on the Firm's Investor Relations website at http://www.morganstanley.com/about-us-ir and on a Form 8-K filed with the Securities and Exchange Commission (SEC) on October 16, 2024, and available on the SEC's website at www.sec.gov. A conference call to discuss the results will be held today at 8:30 a.m. (ET). The call will be available at www.morganstanley.com or by dialing 1-866-431-2040 (domestic) and 1-929-477-0541 (international); the passcode is 400700. Playback will be available via webcast on our website. Morgan Stanley is a leading global financial services firm pr
SC 13G - MORGAN STANLEY (0000895421) (Filed by)
SC 13G/A - MORGAN STANLEY (0000895421) (Filed by)
SC 13G - MORGAN STANLEY (0000895421) (Filed by)